Eli Lilly and Company (NYSE:LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and ...
July 25 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain patients with early Alzheimer's ...
Eli Lilly is promoting its Alzheimer’s medication Kisunla with a national ad campaign centered on hope for treating the disease as well as the importance of early detection and screening. Lilly’s ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
HOUSTON — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to build a new $6.5 billion manufacturing facility at Generation ...
A year after earning FDA approval for Kisunla, Eli Lilly is shining a light on the anti-amyloid Alzheimer’s disease therapy in its first branded campaign. The “Light Up Tomorrow” direct-to-consumer ...
New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, ...
A Mayo Clinic study of 2,750 older adults found chronic insomnia was associated with faster cognitive decline, a 40% higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback